Literature DB >> 6683312

Experimental induction of benzodiazepine tolerance and physical dependence.

G P Ryan, N R Boisse.   

Abstract

To initiate studies of benzodiazepine tolerance and physical dependence, a reproducible animal model has been developed utilizing chlordiazepoxide in rats. Based on the "chronically equivalent" dosing principle, a regimen has been devised to maintain rats in a state of quantifiable intoxication for 5 weeks. Chlordiazepoxide was delivered intragastrically on a b.i.d. basis in doses individually adjusted day-to-day and animal-to-animal to produce an equivalent impairment of motor function evaluated by a gross neurological screen. Quantitative analysis of central nervous system depression ratings during the time of peak effect (4 hr postdose) confirmed that the criterion of chronic equivalence was indeed met. Over the 5-week period of repeated dosing, tolerance was reflected in a 5-fold increase in maintenance dose, from 163.3 mg/kg on day 2 to 839.3 mg/kg on day 35. Tolerance developed more rapidly during the first 9 to 10 days, but continued to develop thereafter more slowly without apparent ceiling. Upon abrupt withdrawal, a syndrome of hyperexcitation developed. Signs included twitches, tremors, muscle hypertonus, arched back, piloerection, myoclonic jerks, augmented struggle and vocalization upon handling, increased startle response, tail erection, teeth chatter, blanched ears and weight loss. No spontaneous convulsions occurred. Latency to onset of withdrawal ranged from 2 to 5 days, and signs peaked in intensity in 8 days and disappeared by 14 days posttreatment. This animal model appears to provide a useful tool for the study of specific mechanisms underlying benzodiazepine tolerance and physical dependence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683312

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines.

Authors:  E Izzo; J Auta; F Impagnatiello; C Pesold; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

3.  Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine/beta-carboline recognition site.

Authors:  M Miyata; I Mocchetti; C Ferrarese; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 4.  Reverse translational strategies for developing animal models of bipolar disorder.

Authors:  Oz Malkesman; Daniel R Austin; Guang Chen; Husseini K Manji
Journal:  Dis Model Mech       Date:  2009 May-Jun       Impact factor: 5.758

5.  Effect of peripheral administration of cinnarizine and verapamil on the abstinence syndrome in diazepam-dependent rats.

Authors:  Y Chugh; N Saha; A Sankaranarayanan; P L Sharma
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.

Authors:  Robert B Raffa; Federica Cavallo; Anna Capasso
Journal:  Eur J Pharmacol       Date:  2007-02-16       Impact factor: 4.432

7.  A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.

Authors:  S E File; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam.

Authors:  I Lucki; R F Kucharik
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats.

Authors:  J Kunchandy; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Purinergic drugs and calcium channel antagonists attenuate the withdrawal syndrome from barbital.

Authors:  A Germany; E Contreras
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.